modelRimegepant_Comisar2025_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral.

Information

name:rimegepant
ATC code:N02CD06
model:two compartments, oral dosing (PK_2C_enteral)
source:Comisar CM et al. 2025
population:pediatric and adult
measured compound:rimegepant
review:accepted with caveats
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
CL/F, L/h25.2L/hCL/F
V1/F, L113LV1/F
V2/F, L46.8LV2/F
Q/F, L/h4.16L/hQ/F
k tr, 1/h8.421/hktr
k a, 1/h3.051/hkabs
fed_on_f1-0.331equation variable
Dose effect on F10.192Fab
body_weight_effect_on_cl_f_and_q_f0.575equation variable
theta_cl_f_hepatic-0.410equation variable
theta_q338_fed-0.698equation variable
theta_ktr_formulation2.19equation variable
theta_cl_f_hepatic-0.203equation variable
theta_v1_f_body_weight1.18equation variable

About rimegepant

Rimegepant is a calcitonin gene-related peptide receptor antagonist used to treat acute migraine attacks in adults. It is an approved medicine and is authorised in the European Union for migraine.

Summary written by glm-5.3-flash from Wikidata Q27272184 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Rimegepant.

References

  1. Comisar CM et al. (2025). Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With Migraine. Clinical and translational science 18(10):e70360. DOI:10.1111/cts.70360 PUBMED:41105969

Parameters

TypeNameDefaultDescription
RealCl_ref7e-06Cl [m3/s]
Realcov_fed_00fed covariate
Realcov_body_weight_10body weight covariate
Realcov_hepatic_20hepatic covariate
Realcov_hepatic_30hepatic covariate
RealVd_ref0.113Vd [m3]
Realcov_body_weight_00body weight covariate
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.0009Volume of distribution peripheral per kg (default 0.9 L/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Comisar_2025: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats